Introduction:

COVID-19 infection produces various symptoms and affects multiple systems, including the endocrine system. Lesions have been documented at the hypothalamic and pituitary axis, hypothetically explained by the presence of angiotensin II receptors in these structures and by direct immune-mediated viral lesions. These manifest with electrolyte and hormonal alterations.

Clinical case:

We present the case of a 46-year-old female patient who, after infection by SARS-CoV-2 confirmed by PCR, presented with hypernatremia refractory to conventional management. Her diagnostic study documented hyposthenuria, high serum osmolarity, and low urinary osmolarity. The condition was corrected with desmopressin, leading to a diagnosis of central diabetes insipidus. A brain MRI revealed a lesion in the pituitary gland, confirming the clinical findings. The only etiological hypothesis for this lesion is its association with SARS-CoV-2 infection.

Conclusion:

Understanding the complications secondary to COVID-19 infection in the endocrine setting, is essential for early diagnosis and targeted treatment. This knowledge can significantly improve the quality of life for patients affected by such complications.

        · resumen en Español     · texto en Español | Inglés     · Español ( pdf ) | Inglés ( pdf )